| Stage | NI | % of rev | DUK | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.3B | 100.00% | $7.6B | 100.00% | DUK ×5.63 |
| Gross profit | $714M | 52.88% | $4.2B | 54.82% | DUK +1.9pp |
| Operating income | $340M | 25.22% | $2.0B | 26.99% | DUK +1.8pp |
| Pre-tax income | $152M | 11.27% | $1.3B | 17.19% | DUK +5.9pp |
| Net income | $139M | 10.30% | $1.1B | 15.08% | DUK +4.8pp |
| Stage | NI | DUK | Gap · A − B |
|---|---|---|---|
| Revenue | $1.3B100.00% | $7.6B100.00% | DUK ×5.63 |
| Gross profit | 52.88%$714M | 54.82%$4.2B | DUK +1.9pp |
| Operating income | 25.22%$340M | 26.99%$2.0B | DUK +1.8pp |
| Pre-tax income | 11.27%$152M | 17.19%$1.3B | DUK +5.9pp |
| Net income |
| 10.30%$139M |
| 15.08%$1.1B |
| DUK +4.8pp |
No shared counterparties.